NCT06859034View on ClinicalTrials.gov

Therapeutic Effect of Proliferative Therapy (prolotherapy) on Pain Using Injectable Hypertonic Dextrose 25% Versus Injectable Dextrose 10% in Retrodiscal Tissues in Patients with Anterior Disc Displacement with Reduction: a Randomized Clinical Trial .

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

September 3, 2025

Study Completion Date

October 31, 2025

Conditions
TMJ Disc Disorder
Interventions
DRUG

injection of dextrose 10% in retrodiscal tissues

group 1 will recieve 10% dextrose in retrodiscal tissues

DRUG

injection of dextrose 25% in retrodiscal tissues

group 2 will recieve 25% dextrose

All Listed Sponsors
lead

Cairo University

OTHER

NCT06859034 - Therapeutic Effect of Proliferative Therapy (prolotherapy) on Pain Using Injectable Hypertonic Dextrose 25% Versus Injectable Dextrose 10% in Retrodiscal Tissues in Patients with Anterior Disc Displacement with Reduction: a Randomized Clinical Trial . | Biotech Hunter | Biotech Hunter